thiophenes has been researched along with Anoxia, Brain in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Afzal, A; Blough, BE; Bossert, JM; Epstein, DH; Fredriksson, I; Hoots, JK; Kiyatkin, EA; Korah, H; Negus, SS; Perekopskiy, D; Shaham, Y; Thomas, S | 1 |
Devi, LA; Fakira, AK; Kennedy, PJ | 1 |
Ameri, K; Bayraktar, O; Maltepe, E; Nguyen, V; Rowitch, DH; Sabeur, K | 1 |
Ano, M; Hirata, K; Kitamura, K; Maekawa, M; Narita, H; Ono, S; Ukai, W; Yamafuji, T | 1 |
Auguet, M; Chabrier, PE; Cornet, S; Demerlé-Pallardy, C; Marin, JG; Spinnewyn, B | 1 |
5 other study(ies) available for thiophenes and Anoxia, Brain
Article | Year |
---|---|
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.
Topics: Analgesics, Opioid; Animals; Extinction, Psychological; Female; GTP-Binding Proteins; Humans; Hypoxia, Brain; Male; Oxycodone; Rats; Receptors, Opioid, mu; Recurrence; Self Administration; Spiro Compounds; Thiophenes | 2020 |
Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention.
Topics: Analgesics, Opioid; Animals; GTP-Binding Proteins; Hypoxia, Brain; Oxycodone; Rats; Receptors, Opioid, mu; Recurrence; Secondary Prevention; Spiro Compounds; Thiophenes | 2020 |
Sonic Hedgehog Agonist Protects Against Complex Neonatal Cerebellar Injury.
Topics: Amino Acids, Dicarboxylic; Animals; Animals, Newborn; Anti-Inflammatory Agents; Basic Helix-Loop-Helix Transcription Factors; Calcium-Binding Proteins; Cell Proliferation; Cells, Cultured; Cerebellum; Cyclohexylamines; Developmental Disabilities; Disease Models, Animal; Gene Expression Regulation, Developmental; Glucocorticoids; Hedgehog Proteins; Hypoxia, Brain; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Nerve Tissue Proteins; Nervous System Malformations; Neuroprotective Agents; Prednisolone; Purkinje Cells; Thiophenes; Von Hippel-Lindau Tumor Suppressor Protein; Zinc Finger Protein GLI1 | 2018 |
Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Diethylamines; Energy Metabolism; Glycolysis; Hypoxia, Brain; Imipramine; Male; Mice; Mice, Inbred Strains; Pentobarbital; Potassium Cyanide; Scopolamine; Sleep; Tacrine; Thiophenes | 1993 |
BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures.
Topics: Animals; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Dinoprost; Enzyme Inhibitors; F2-Isoprostanes; Hypoxia, Brain; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Neuroprotective Agents; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Thiophenes | 2000 |